Recall - Children's and Infants' Tylenol Oral Suspension Products

m Bookmark and Share
The American Nurses Association (ANA) provides the following information for Consumers and Healthcare professionals received from U.S. Food & Drug Administration (FDA):

McNeil Consumer Healthcare and FDA notified consumers of a nationwide recall of certain Tylenol products as a precautionary measure because of potential manufacturing problems. The company initiated a recall of certain oral suspension products distributed between March 2008 and May 2008 due to the potential of bacteria in raw materials used to manufacture the finished product. There are no illnesses reported by patients using this product. The full list of recalled product lots can be accessed on the company’s Web site. McNeil is advising parents and caregivers who have administered affected product to their child or infant and have concerns to contact their healthcare providers. Parents and caregivers can find the lot numbers on the bottom of the box containing the product and also on the sticker that surrounds the product bottle.

Read the complete MedWatch 2009 Safety summary including a link to the FDA news release, at: 

You are encouraged by the FDA to report all serious adverse events and product quality problems to FDA MedWatch